Loading...
Market
What will be the primary application area of the Virchow2G model in clinical settings by December 31, 2024?
2
Resolution / Starting Odds
Breast Cancer Diagnosis • 25%
Lung Cancer Diagnosis • 25%
Prostate Cancer Diagnosis • 25%
Other • 25%
Official usage reports and announcements from hospitals and Paige
Story
Microsoft and Paige Launch Virchow2G AI Models for Cancer Diagnosis, Scaling to 1.85 Billion Parameters
Aug 15, 2024, 01:31 PM
Microsoft and Paige have collaborated to develop Virchow2 and Virchow2G, second-generation foundation models for computational pathology. These models are designed to enhance cancer diagnosis by leveraging AI and self-supervised learning techniques. The Virchow2G model significantly increases the scale of previous work, reaching 1.85 billion parameters. A paper published in Nature Medicine highlights the original Virchow model, trained on 1.5 million whole-slide images from 10,000 patients, which has improved the detection of rare cancers. This advancement represents a strategic pivot for Paige, aiming to further the role of AI in cancer care. Virchow2 and 2G are now available on Hugging Face.
View original story
Similar markets
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Other • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Johns Hopkins Hospital • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Forensic Science • 25%
Orthodontics • 25%
Pediatric Dentistry • 25%
General Diagnostics • 25%
Neurology • 25%
Oncology • 25%
Cardiology • 25%
Other • 25%
Yes • 50%
No • 50%
1 to 3 • 25%
4 to 6 • 25%
7 to 9 • 25%
10 or more • 25%
Yes • 50%
No • 50%
Less than 10 • 25%
10 to 20 • 25%
21 to 50 • 25%
More than 50 • 25%